Vyas Bio Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 10-12-2024
- Paid Up Capital ₹ 0.90 M
as on 10-12-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 10-12-2024
- Satisfied Charges ₹ 1.20 M
as on 10-12-2024
- Revenue 57.74%
(FY 2023)
- Profit 42.68%
(FY 2023)
- Ebitda 7.18%
(FY 2023)
- Net Worth 468.41%
(FY 2023)
- Total Assets 119.96%
(FY 2023)
About Vyas Bio Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Nagalakshmi Jami and Ramakrishna Jami serve as directors at the Company.
- CIN/LLPIN
U01403TG2008PTC062092
- Company No.
062092
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Dec 2008
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vyas Bio Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagalakshmi Jami  | Director | 03-Dec-2008 | Current |
| Ramakrishna Jami | Director | 03-Dec-2008 | Current |
Financial Performance of Vyas Bio Life Sciences.
Vyas Bio Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.74% increase. The company also saw a substantial improvement in profitability, with a 42.68% increase in profit. The company's net worth Soared by an impressive increase of 468.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vyas Bio Life Sciences?
Unlock access to Vyas Bio Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Sep 2024 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 09 Jun 2017 | ₹1.20 M | Satisfied |
How Many Employees Work at Vyas Bio Life Sciences?
Unlock and access historical data on people associated with Vyas Bio Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vyas Bio Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vyas Bio Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
